HIGHLIGHTS
Extensive LA fibrosis is related to an increase in LA size and decrease in total LA EF. This supports the contention that the LA is not merely a bystander of MR but rather is actively involved in the pathophysiology of MR.
Chymase is plentiful in the human heart, especially in the LA, and correlates with extracellular matrix accumulation in primary MR.
Because of the unreliability of the LV ejection fraction in primary MR, future studies may consider LA size and total LA EF for timing of surgical intervention of asymptomatic moderate to severe MR.
SUMMARY
Increasing left atrial (LA) size predicts outcomes in patients with isolated mitral regurgitation (MR). Chymase is plentiful in the human heart and affects extracellular matrix remodeling. Chymase activation correlates to LA fibrosis, LA enlargement, and a decreased total LA emptying fraction in addition to having a potential intracellular Left atrial (LA) size is associated with a poor prognosis, despite LV ejection fractions of >60% (4, 5) . A number of studies have identified extensive LA myolysis, mitochondrial damage, and interstitial fibrosis in patients with degenerative MR (6) (7) (8) (9) . However, these ultrastructural changes are not connected to LA volumes or to the LA total emptying fraction (LA EF).
Total LA EF and LA minimum volume have been shown to correlate with LV end-diastolic pressure obtained at cardiac catheterization (10).
We reported increased chymase activity in the LA of patients who underwent the MAZE procedure (Surgical procedure creating a pattern or "maze" of scar tissue in the atria to treat atrial fibrillation.) for atrial fibrillation (11). Chymase is an abundant protein in the human heart with highly efficient angiotensin factor (TGF)-b and conversion of prepro endothelin 1 to endothelin 1, which results in increased extracellular matrix production (12). Chymase also degrades fibronectin, which leads to cell apoptosis and activates matrix metalloproteinases, multiple cytokines, and stem cell factor that mediates inflammatory cell infiltration (12). In addition to these extracellular actions, there is emerging evidence of chymase within cardiomyocytes, which raises the possibility of intracellular protease targets (13, 14) . Butts et al.
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F E B R U A R Y 2 0 2 0 : 1 0 9 -2 2 activity as described previously by our laboratory (13).
For details, see the Supplemental Appendix.
CHYMASE mRNA PRODUCTION BY IN SITU HYBRIDIZATION.
The expression of human chymase (CMA1) mRNA was measured by in situ hybridization as previously described by our laboratory (13 Supplemental Table 1 lists the demographic data on Figure 1 .
Butts et al. Butts et al.
20 patients with MR, and Supplemental Table 2 lists the underlying cardiac conditions in the control subjects with nonfailing hearts. Supplemental Table 3 presents the MR regurgitant volume (median 54 ml) and regurgitant fraction (median 44%), both of which were consistent with severe MR. Figure 1A demonstrates a nearly 2-fold increase in MR LV end-diastolic volume; however, LV ejection fraction did not differ from the age-matched normal subjects. In contrast,
LA maximum and minimum volumes were increased 2-and 3-fold, respectively, and total LA EF was decreased below that in age-matched normal subjects Butts et al. The marked fibrosis and ultrastructural damage in the LA provided further insight into our previous report of LA remodeling and dysfunction in patients with MR after MV repair (19) . One-year post-surgery, despite a decrease in LA maximum and minimum volumes (20) , there was a significant decrease in multiple diastolic variables below normal, including total LA EF. In the present study, a similar group of Butts et al. It is tempting to speculate that the greater amount of chymase activity in the thin-walled human LA, in addition to excessive stretch of MR, might make it especially prone to acute injury and subsequent fibrosis, atrial fibrillation, and a decline in the total LA EF.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E
Another cause for the decline in LA function was the marked amount of myofibrillar degeneration by TEM and atrial myolysis by hematoxylin and eosin and Western blot. In addition to the extracellular location of chymase, we reported chymase within cardiomyocytes of rats with volume overload of the aorto-caval fistula (13) and in dogs with ischemiaÀreperfusion injury (14) . We showed a similar presence of chymase within LA myocytes by TEM immunogold that was functionally verified by in situ chymotryptic activity within the MR LA myocytes. Chymase uptake in adult rat cardiomyocytes causes myosin breakdown that is attenuated by a dynamin inhibitor that prevents chymase uptake (14) .
Long-term treatment with an oral chymase inhibitor preserved desmin and myosin architecture and cardiomyocyte function in dogs with experimentally induced MR (22) . In a subsequent analysis of these same dogs, chymase inhibition decreased LA fibrofatty infiltration, preserved myocyte architecture, and significantly increased atrial booster pump function (Supplemental Figure 2) . In this pre-clinical study, dogs had only the alpha isoform of chymase that was most similar to humans, whereas rodents had both alpha and multiple beta isoforms that degraded rather than formed angiotensin II.
Taken together with the results of in situ hybridization, these data supported the contention that the presence and activity of chymase within cardiomyocytes was largely due to uptake from adjacent cells, with minimal evidence of cardiomyocyte in situ 
